As of the latest SEC filings, Dyne Therapeutics, Inc. (DYN) is held by 229 institutional funds. The largest fund shareholder is T. Rowe Price Small-Cap Stock Fund, Inc. (OTCFX), holding an estimated $127,131,222.26 in market value, representing 1.58% of its portfolio.
Funds holding Dyne Therapeutics, Inc. (DYN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DYN
- CIK:
- 0001818794
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 1.58% | $127,131,222.26 | 7,012,202 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $84,225,398.81 | 4,645,637 | Mar 31, 2026 | May 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.91% | $83,852,718.53 | 4,625,081 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 1.59% | $69,070,241.73 | 3,809,721 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.84% | $62,322,310.12 | 3,437,524 | Mar 31, 2026 | May 28, 2026 |
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.09% | $59,460,398.97 | 3,279,669 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.08% | $58,978,358.53 | 3,253,081 | Mar 31, 2026 | May 28, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.88% | $45,836,701.12 | 2,528,224 | Mar 31, 2026 | May 29, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.02% | $30,944,900.42 | 1,706,834 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.04% | $29,066,559.90 | 1,603,230 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.03% | $27,400,682.10 | 1,754,205 | Feb 28, 2026 | Apr 24, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.07% | $23,127,372.45 | 1,317,799 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.40% | $21,370,409.28 | 1,368,144 | Feb 28, 2026 | Apr 24, 2026 |
|
VISVX
VANGUARD SMALL-CAP VALUE INDEX FUND
|
ETF | Vanguard | 0.03% | $19,703,484.57 | 1,086,789 | Mar 31, 2026 | May 28, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 0.81% | $17,571,342.18 | 969,186 | Mar 31, 2026 | May 29, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.20% | $16,633,731.10 | 917,470 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.12% | $15,824,317.25 | 872,825 | Mar 31, 2026 | May 28, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.11% | $14,097,398.49 | 777,573 | Mar 31, 2026 | May 28, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 2.47% | $13,850,576.67 | 763,959 | Mar 31, 2026 | May 29, 2026 |
|
-
JNL/T. Rowe Price Capital Appreciation Fund
|
ETF | Independent / Boutique | 0.09% | $12,532,507.54 | 691,258 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.06% | $12,082,285.25 | 666,425 | Mar 31, 2026 | May 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $11,768,764.04 | 753,442 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $10,936,717.88 | 700,174 | Feb 28, 2026 | Apr 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.13% | $10,558,349.97 | 582,369 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.06% | $9,577,934.08 | 613,184 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)